Drug Profile
AM 630
Latest Information Update: 12 Nov 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Cannabinoid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anorexia nervosa
Most Recent Events
- 04 Dec 2000 Preclinical development for Anorexia nervosa in USA (Unknown route)